Telegram RegisterThe public register of Telegram
Telegram profile photo for 바이오도 간다!

Channel

바이오도 간다!

@kkk595959

On this record: Topic · Growth · Engagement · Posts · Citations · Telegram's recommendations · Cite this entry

5,727subscribers

-37 since we began measuring on 7 August 2026

Risers and fallers across the register · movement among entries of 3,162–10,000.

Register entry

Telegram ID-1001166380746
TypeChannel
Username@kkk595959
CreatedBetween 1 March 2018 and 31 July 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded7 August 2026
Last confirmed live17 September 2026
Measurements held14
Confirmed unchanged1 time, most recently 17 September 2026
On Telegramt.me/kkk595959

Topic

Other / unclassifiable — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 12 September 2026 and assigned it the closest of 31 fixed categories, at 59% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.

Growth

5,7225,7645,7437 August 2026 — 5,764 subscribers7 August 2026 — 5,764 subscribers11 August 2026 — 5,761 subscribers14 August 2026 — 5,752 subscribers17 August 2026 — 5,745 subscribers20 August 2026 — 5,731 subscribers24 August 2026 — 5,729 subscribers26 August 2026 — 5,743 subscribers29 August 2026 — 5,739 subscribers1 September 2026 — 5,733 subscribers4 September 2026 — 5,730 subscribers9 September 2026 — 5,732 subscribers13 September 2026 — 5,722 subscribers17 September 2026 — 5,727 subscribers5,7277 August 202617 September 2026
14 measurements spanning 41 days, net -37. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 5,716–5,770 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
17 Sept 2026, 10:405,727+5
13 Sept 2026, 17:385,722-10
9 Sept 2026, 19:225,732+2
4 Sept 2026, 17:415,730-3
1 Sept 2026, 01:385,733-6
29 Aug 2026, 06:535,739-4
26 Aug 2026, 17:025,743+14
24 Aug 2026, 00:565,729-2
20 Aug 2026, 06:245,731-14
17 Aug 2026, 12:585,745-7
14 Aug 2026, 13:455,752-9
11 Aug 2026, 05:065,761-3
7 Aug 2026, 14:015,764no change
7 Aug 2026, 13:545,764first reading

Engagement

20 posts held, back to 16 July 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 7 pages of Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 6 August 2026. An engagement rate over an empty window would be a number about nothing.

Recent posts

6 Aug 2026, 06:02 UTC449 viewsread 12 August 2026
Forwarded from @aprilbioiprPhoto

오는 9월 30일 EADV학회에서 APB-R3 2a상 탑라인 결과발표가 예정되어있습니다. 제목이 ‘positive’ data발표라는 점이 눈에 띕니다.

4 Aug 2026, 22:48 UTC≈5,480 viewsread 12 August 2026

2026.08.05 07:41:35 기업명: 알테오젠(시가총액: 18조 5,945억) A196170 보고서명: 투자판단관련주요경영사항 (재조합 인간 히알루로니다제 제품 ALTB4 독점적 라이선스 계약 체결) 제목 : 재조합 인간 히알루로니다제 제품 ALT-B4 독점적 라이선스 계약 체결 * 주요내용 ※ 투자유의사항 본 계약은 의약품규제기관의 허가가 완료되어야 이행되는 조건부 계약으로서, 본 계약을 통한 수익 인식은 임상시험과 품목허가 등의 성공 여부에 따라 달라질 수 있습니다. 계약 조건에 따라, 규제기관에 의한 연구 개발의 중단, 품목허가 실패 등 발생시 계약이 해지될 수 있습니다. 1. 계약상대방: 비공개 2. 계약의 내용: 알테오젠의 하이브로자임 플랫폼 기반 재조합 인간 히알루로니다제 ALT-B4를 적용한

27 Jul 2026, 23:33 UTC≈2,200 viewsread 12 August 2026

https://n.news.naver.com/article/014/0005553660?sid=101

22 Jul 2026, 07:27 UTC≈1,690 viewsread 12 August 2026
Forwarded from @darthacking

2026.07.22 16:20:48 기업명: 삼성에피스홀딩스(시가총액: 9조 2,565억) A0126Z0 보고서명: 투자판단관련주요경영사항(자회사의 주요경영사항) (Nectin4 단백질 표적 고형암 치료제 후보물질 SBE303 연구개발 및 상업화 계약 체결) 종속회사 : 삼성바이오에피스 제목 : Nectin-4 단백질 표적 고형암 치료제 후보물질 SBE303 연구개발 및 상업화 계약 체결 * 주요내용 ※ 투자유의사항 동 계약은 조건부 계약으로서, 본 계약을 통한 비용 인식은 임상시험과 품목허가 등의 성공 여부에 따라 달라질 수 있습니다. 계약 조건에 따라, 규제기관에 의한 연구·개발의 중단, 품목허가 실패 등 발생시 계약이 해지될 수 있습니다. 1) 계약 상대방 : - (주)인투셀 (한국, 이하 "인투셀")

21 Jul 2026, 00:29 UTC≈2,280 viewsread 12 August 2026

아직도 신용 일으킬 코스닥 주식이 남아잇다니....ㅔ.. 아직도 레버리지가 살아잇다니...

21 Jul 2026, 00:27 UTC≈1,810 viewsread 12 August 2026
Forwarded from @valuefinder

들리는 소식에 의하면 신용으로 전닉 레버(레버리지 ETF 아님) 일으키신 분들이 담보부족 뜨면 코스닥 주식을 팔아서 버틴다고...

21 Jul 2026, 00:14 UTC≈1,730 viewsread 12 August 2026
Forwarded from @athletes_villagePhoto

하락이 계속되면 하락노예근성이 생김 노예해방은 온다 https://t.me/athletes_village/22914

Showing the 12 most recent of 20 posts we hold for @kkk595959. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Names

Channels on the register whose handles appear in this channel's posts.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Appears in Telegram’s recommendations for other channels

The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.

허혜민의 제약/바이오 소식통
@huhpharm · 24,282
Telegram ranks this channel #38 of 93 here — alongside 92 others — read 16 September 2026

This channel appears in 1 seed channel's Telegram-generated recommendation list in total. Each is Telegram’s list for THAT channel, not this one — see how this is measured.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 17 September 2026 — this entry's latest reading, not the date you are reading this.

“바이오도 간다!” (@kkk595959), 5,727 subscribers as measured 17 September 2026. Telegram Register, tgregister.com/channel/kkk595959.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.